[A case of hepatocellular carcinoma treated with specific substance of Maruyama resulting in a partial response]

Tatsunori Mizuno; Tatsuro Ikezoe; Kaori Kotani; Takeo Yoshihara; Toru Sanada; Daisuke Yamaguchi; Makiyo Ota; Yasukazu Goto; Yorihide Okuda; Masayoshi Horimoto; Kunio Suzuki

[A case of hepatocellular carcinoma treated with specific substance of Maruyama resulting in a partial response]

Gan To Kagaku Ryoho. 2013 Nov;40(12):1862-4.

[Article in Japanese]

Authors

Tatsunori Mizuno¹, Tatsuro Ikezoe, Kaori Kotani, Takeo Yoshihara, Toru Sanada, Daisuke Yamaguchi, Makiyo Ota, Yasukazu Goto, Yorihide Okuda, Masayoshi Horimoto, Kunio Suzuki

Affiliation

¹ Dept. of Internal Medieine, Saiseikai Senri Hospital.

PMID: 24393947

Abstract

We treated a 41-year-old man with hepatocellular carcinoma and chronic liver disease. He experienced leg edema. Following additional examinations, we diagnosed the patient with hepatocellular carcinoma and ascites with liver cirrhosis. Due to renal dysfunction, he could not undergo treatment with transcatheter arterial chemoembolization(TACE)or transcatheter arterial infusion(TAI). Therefore, he was treated with specific substance of maruyama(SSM), and survived.

Publication types

Case Reports
English Abstract

MeSH terms

Adult
Ascites / etiology
Cancer Vaccines / therapeutic use*
Carcinoma, Hepatocellular / etiology
Carcinoma, Hepatocellular / therapy*
Embolization, Therapeutic
Humans
Liver Cirrhosis / complications
Liver Cirrhosis / therapy*
Liver Neoplasms / etiology
Liver Neoplasms / therapy*
Male

Substances

Cancer Vaccines